Paratesticular Metastasis of Malignant Melanoma: A Case Report  by Acar, Omer et al.
Kaohsiung J Med Sci June 2008 • Vol 24 • No 6 315
© 2008 Elsevier. All rights reserved.
Metastatic tumors involving paratesticular tissues are
extremely rare. To our knowledge, melanoma metas-
tatic to paratesticular tissues has not been reported 
to date. Here, we report a case of widely metastatic
malignant melanoma that was diagnosed after histo-
pathologic examination of the excised paratesticular
mass.
CASE PRESENTATION
A 50-year-old male patient initially visited the neuro-
surgery clinic due to low back pain. On physical exam-
ination, a subcutaneous mass was noted in the right
lumbar region. The overlying skin had a deep purple
color. Moreover, a right hemiscrotal painless mass
extending to the inguinal region was palpated. The
patient reported that the lumbar mass was congenital,
and no significant change regarding size, consistency
and color had been evident recently. However, the
scrotal mass had progressively increased in size during
the previous few months.
Spinal magnetic resonance imaging (MRI) revealed
metastatic deposits in the vertebral bodies. Computed
tomography (CT) of the abdomen revealed hepatic
metastatic nodules and pathologically enlarged lymph
nodes. A CT scan localized the subcutaneous protu-
berant soft tissue mass, measuring 5×7cm in diameter,
in the right lumbar region. Since the mass was con-
genital and had not recently increased in size, it was
neither excised nor biopsied. The relationship between
the paratesticular mass (9 cm in greatest dimension)
and the right testis was not clear on CT imaging
(Figure 1). Upon these findings, Tru-cut biopsy speci-
mens were obtained from hepatic metastatic nodules
and the T12 vertebral body. Pathologic analysis of 
the hepatic biopsy specimen revealed metastasis of 
a carcinoma. The primary site could not be identified
based on histopathologic data. Osseous findings were
nonspecific and inadequate for a particular diag-
nosis. The blood chemistry profile was normal with
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We report a case of multimetastatic malignant melanoma that was diagnosed after histopathologic
examination of the excised paratesticular mass. Our patient initially visited the neurosurgery
clinic due to low back pain. After preliminary evaluation, he was referred to our clinic due to a
right scrotal mass. We excised the paratesticular mass and testis. The histopathologic findings
were consistent with malignant melanoma. He was referred to the oncology department for adju-
vant treatment. The patient died during the third month of chemotherapy. Our case was unique
because the malignant melanoma was widely metastatic and involved primarily paratesticular
tissues without any invasion of the testis and epididymis.
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serum tumor markers (α-fetoprotein, human chorionic
gonadotropin) being within the normal range.
The patient was referred to our clinic due to his
right scrotal mass. Imaging studies were inconclusive
about the nature of the mass and its relationship with
testicular tissue. Therefore, we decided to perform sur-
gical exploration. On surgical exploration, the highly
vascular paratesticular mass was found to be separated
from the right testis with a poorly defined pseudocap-
sule. Moreover, numerous satellite lesions of smaller
size, but similar vascularity, were located in the ingui-
nal region. These satellite lesions, extending caudally,
were probably related to the giant subcutaneous lum-
bar mass. We performed a right radical orchiectomy
and excised the paratesticular mass by an inguinal
incision. The mass, weighing 760 g, was localized to
paratesticular tissues on both macroscopic and micro-
scopic examination (Figure 2A). The testis and epi-
didymis were free of tumoral infiltration. However,
microscopic tumoral invasion was evident in the sper-
matic cord and tunica vaginalis. Tumoral cells were
pigmented and highly pleomorphic. Immunohisto-
chemical staining with S100, HMB-45 and melan-A
confirmed the diagnosis of malignant melanoma
(Figure 2B). Hepatic biopsy specimens were then re-
evaluated with the same immunohistochemical panel.
The immunohistochemical profile was almost the same
in the hepatic biopsy specimens. Although negative
for S100, immunopositivity for HMB-45 and melan-A
confirmed the diagnosis of malignant melanoma. Upon
these findings, it was concluded that the hepatic lesions
were metastatic deposits of malignant melanoma.
After an uneventful postoperative period, the pa-
tient was discharged from hospital on the second day.
He was referred to the oncology department for adju-
vant treatment. Oncologists initiated a 3-month course
of dacarbazine treatment. The patient died during
the third month of chemotherapy, before completion
of the first cycle.
DISCUSSION
Intrascrotal tumors can be testicular or paratesticular in
origin. Although most paratesticular masses are benign
in nature, 30% of such tumors are malignant [1–4]. Dif-
ferential diagnoses of malignant paratesticular masses
primarily include liposarcoma, rhabdomyosarcoma
Figure 1. Computed tomography demonstrates a right scrotal
mass with an indefinite relationship with the testicle.
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Figure 2. (A) Pigmented atypical cells invading the paratesticular area (hematoxylin & eosin, 150×). (B) HMB-45 immunopositivity
in tumoral cells (360×).
and leiomyosarcoma. Identifying the origin of these
masses necessitates additional evaluation that typically
consists of an imaging study and serum tumor mark-
ers. Clinical and radiologic findings may resemble tes-
ticular tumors and yield inconclusive findings about
the nature and biological behavior of such masses.
Therefore, surgical exploration may eventually be nec-
essary in the majority of cases. Definitive diagnosis is
made by histopathologic examination of the excised
specimen.
Metastatic tumors of the testes and paratesticular
tissues are relatively uncommon. Tumors metastasiz-
ing to the testis comprise 1% of all testis tumors [1].
The tumors most commonly reported to metastasize
to the testis are prostate, lung, melanoma, colon, kid-
ney, stomach and pancreas tumors. In about 15% of
cases, these are metastases of malignant melanomas
[2–3]. There are about 30 reports of such cases in the
literature [1–4]. Most metastatic melanomas metasta-
sizing to the testis have been incidentally found at
autopsy in patients with widespread malignant mel-
anoma [5]. In only four of the previously described
cases of testicular metastases were the first manifesta-
tion of a malignant melanoma [6]. For primary tumors
outside the abdominal or pelvic cavities, the arterial
routes appear most likely, although metastatic involve-
ment of intra-abdominal organs or lymph nodes may
lead to testicular or paratesticular involvement by
retrograde invasion through veins or lymph vessels
[1–3,7]. Purely paratesticular metastatic deposits are
extremely rare with only a few cases, such as renal
cell carcinoma, Wilm’s tumor and pancreatic cancer
metastasizing to the paratesticular space, having been
reported so far [8,9].
Melanoma is a malignant melanocytic tumor aris-
ing in pigmented areas. Melanomas represent 3% of
all cancers (excluding non-melanoma skin cancer)
and 1–2% of all cancer deaths [10]. The probability of
metastasis may be predicted by measuring the depth
of invasion of the vertical growth phase. Metastasis
involves not only regional lymph nodes, but also
liver, lungs, brain and virtually any other site that can
be seeded by the hematogenous route [7]. A review of
100 autopsy studies of patients dying of metastatic
melanoma showed an autopsy incidence of occult me-
tastases to organs of the genitourinary system com-
parable to that of other viscera [5]. The most frequent
sites of occult genitourinary melanoma metastases
are the adrenals (38%), kidneys (34%), and bladder
(14%), with testicular involvement to a lesser extent
(6%) [5].
Initial presentation of occult nongonadal malig-
nancy as a clinically apparent testicular mass is rare.
A literature review indicated no previously reported
cases of melanoma with the testicle as the presenting
metastatic site. Moreover, to our knowledge, this is
the first case of metastatic malignant melanoma in-
volving paratesticular tissues. This widely metastatic
disease was identified based on histopathologic ex-
amination of the excised mass. Once a testicular tumor
is discovered to be a metastasis of malignant mela-
noma, the prognosis is very poor regardless of the
treatment modality. Chemotherapy (dacarbazine or
the nitrosureas carmustine and lomustine) and immu-
notherapy with the bacille Calmette-Guerin vaccine or
interleukin-2 represent the current treatment options
for metastatic disease. In metastatic testicular mela-
noma, the life expectancy after orchiectomy ranged
from 2 to 14 months [5]. Our patient survived for only
3 months after the operation, despite the initiation of
chemotherapy.
In our case, imaging studies were inconclusive as
to the nature of the mass and its relationship with tes-
ticular tissue. Therefore, we decided to perform sur-
gical exploration. It was found that the mass was
paratesticular in origin. Moreover, histopathologic
examination of the excised mass explained the whole
picture, and the patient received adjuvant treatment
accordingly.
To sum up, paratesticular metastasis of melanoma
is an extremely rare condition. Our case was unique
because the melanoma was widely metastatic and
primarily involved paratesticular tissues without any
invasion of the testis and epididymis. However, prog-
nosis is not expected to be better than that of testicu-
lar metastasis due to widely systemic disease and late
presentation.
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